Precision BioSciences Inc has a consensus price target of $16, established from looking at the 19 latest analyst ratings. The last 3 analyst ratings were released from Guggenheim, HC Wainwright & Co., and HC Wainwright & Co. on April 30, 2024, April 17, 2024, and March 28, 2024. With an average price target of $46.33 between Guggenheim, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 308.58% upside for Precision BioSciences Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|
The latest price target for Precision BioSciences (NASDAQ: DTIL) was reported by Guggenheim on April 30, 2024. The analyst firm set a price target for $19.00 expecting DTIL to rise to within 12 months (a possible 67.55% upside). 10 analyst firms have reported ratings in the last year.
The latest analyst rating for Precision BioSciences (NASDAQ: DTIL) was provided by Guggenheim, and Precision BioSciences initiated their buy rating.
There is no last upgrade for Precision BioSciences.
The last downgrade for Precision BioSciences Inc happened on March 14, 2023 when BMO Capital changed their price target from $7 to $4 for Precision BioSciences Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Precision BioSciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Precision BioSciences was filed on April 30, 2024 so you should expect the next rating to be made available sometime around April 30, 2025.
While ratings are subjective and will change, the latest Precision BioSciences (DTIL) rating was a initiated with a price target of $0.00 to $19.00. The current price Precision BioSciences (DTIL) is trading at is $11.34, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.